<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="211128">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00338546</url>
  </required_header>
  <id_info>
    <org_study_id>2RO1DA01006409</org_study_id>
    <nct_id>NCT00338546</nct_id>
  </id_info>
  <brief_title>Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine</brief_title>
  <official_title>Cocaine and Sympathetic Nerve Activity in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve the scientific understanding of the cardiovascular
      actions of cocaine, in particular the ability of cocaine to increase blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cocaine abuse has emerged as a major cause of life-threatening cardiovascular emergencies
      but our understanding of the underlying mechanisms mediating the adverse effects of cocaine
      is far from complete. Our previous studies in cocaine-naive human subjects have demonstrated
      that intranasal cocaine acutely stimulates the human cardiovascular system by a novel
      central mechanism of action.We are currently investigating a central sympatholytic
      drug,dexmedetomidine, in reversing the sympathomimetic effects (increase in blood pressure,
      heart rate and coronary vasoconstriction) of intranasal cocaine.This drug may be a new
      pharmacologic agent in the treatment of acute cocaine intoxication in humans.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin sympathetic nerve activity</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin blood flow</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronary blood flow</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sedation status</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Cocaine Induced Sympathoexciation and Vasoconstriction</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cocaine hydrochloride</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microneurography</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser doppler velocimetry</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cocaine naive healthy volunteers

        Exclusion Criteria:

          -  Any evidence of cardiopulmonary disease by history or physical examination

          -  History of hypertension or 24 hour blood pressure averaging &gt;135/85 mmHg

          -  Any history of substance abuse (other than tobacco)

          -  Diabetes mellitus or other systemic illness

          -  Individuals with a history of pseudocholinesterase deficiency

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald G Victor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wapen Vongpatanasin, MD</last_name>
    <phone>214-648-9078</phone>
    <email>wanpen.vongpatanasin@utsouthwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dileep V Menon, MD</last_name>
    <phone>214-648-7941</phone>
    <email>dileep.menon@utsouthwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Univ of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanpen Vongpatanasin, MD</last_name>
      <phone>214-648-9078</phone>
      <email>wanpen.vongpatanasin@utsouthwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dileep V Menon, MD</last_name>
      <phone>214-648-7941</phone>
      <email>dileep.menon@utsouthwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald G Victor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999 Aug 3;100(5):497-502.</citation>
    <PMID>10430763</PMID>
  </results_reference>
  <verification_date>May 2009</verification_date>
  <lastchanged_date>May 19, 2009</lastchanged_date>
  <firstreceived_date>June 16, 2006</firstreceived_date>
  <keyword>Cocaine</keyword>
  <keyword>Sympathetic nerve activity</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Cutaneous vasoconstriction</keyword>
  <keyword>Coronary vasoconstriction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
